Results for “”

Entry Author Date Location
Adimab Spinout Adagio Raises $50M for Coronavirus Antibody R&D 07/16/20 Boston
Moderna Publishes Early COVID-19 Vaccine Data, Preps for Phase 3 Test 07/15/20 Boston
Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 07/15/20 Boston
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
Scholar Rock CEO Mahanthappa to Step Down, Kingsley Named Successor 07/14/20 Boston
Vor Biopharma Makes Slapak’s Chief Medical Officer Job Permanent 07/14/20 Boston
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact 07/14/20 Boston
New Xconomy Podcast & Special Report Feature Boston Biophama Leaders on Digital Health 07/14/20 Boston
Amgen Doubles Down on BeiGene Collaboration, Investing $421M More 07/13/20 San Francisco
Ovid Licenses European Rights to Lead Rare Disease Drug to Angelini Pharma 07/13/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership 07/09/20 Boston
Biogen Alzheimer’s Drug in FDA’s Court Following Completion of Filing 07/08/20 Boston
Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck 07/08/20 Boston
Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine 07/07/20 National
Cyteir Adds Chief Scientific Officer & Chief Business Officer to C-Suite 07/07/20 Boston
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
PacBio CEO, CFO Plan Retirements and More People on the Move 07/07/20 National
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients 07/02/20 National
BioNTech’s mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity 07/01/20 Europe
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s 07/01/20 Boston
Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases 07/01/20 Boston
Akcea Therapeutics Names Tracy Palmer Berns Chief Compliance Officer 06/30/20 Boston
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later 06/30/20 Boston
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More 06/26/20 National
CSL Behring Bolsters Hemophilia Lineup With Deal for uniQure’s Gene Therapy 06/25/20 Philadelphia
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs 06/25/20 Boston
Page 2 of 671 « previous page · next page »